The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
“The bowel management systems market is projected to grow at a CAGR of 3.5%.”
The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5%. Expanding target patient population, rapidly growing geriatric population, availability of technologically advanced bowel management products, and favorable reimbursement scenario in developed countries are expected to drive the demand for bowel management systems during the study period. On the other hand, factors such as discomfort associated with the use of bowel management devices and patient preference for noninvasive clinical management of FI are restraining the growth of the bowel management systems market.
“The adult patient is expected to dominate the bowel management systems market in 2018”
The market is segmented into adult and pediatric patients on the basis of patient type. The adult patients segment is expected to account for the largest share in the bowel management systems market in 2018. The significant prevalence of FI among adults, increased public-private initiatives to enhance patient awareness related to effective FI management, availability of advanced bowel management products, and the availability of reimbursement in developed countries are expected to drive the growth of this market segment during the study period.
“The home care segment to dominate the bowel management systems market in 2018”
The market is segmented into home care and hospitals & ambulatory surgery centers on the basis of end user. The home care segment is expected to account for the largest share of the bowel management systems market in 2018. Factors such as the significant usage and growing adoption of bowel management products in home care settings, need for device replacement on a regular basis, and rising incidence of chronic disorders are expected to drive the growth of the home care segment in the coming years.
“RoW is expected to register the highest growth rate in the bowel management systems market”
Geographically, the bowel management systems market is segmented into North America, Europe, Asia Pacific, and the RoW. The RoW is projected to be the fastest-growing regional segment in the bowel management systems market. The Rest of the World (RoW) comprises Latin America (including Brazil, Mexico, Peru, and Chile), the Middle East (including Egypt, Iran, Turkey, and Iraq), and Africa (including South Africa, Egypt, Ghana, and Nigeria). The growing target patient population, ongoing expansion of healthcare infrastructure, and initiatives to enhance patient awareness are the factors expected to drive the growth of the market in the RoW region.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the market.
- By Company Type: Tier I: 45%, Tier II: 34%, and Tier III: 21%
- By Designation: C-Level: 14%, Director-Level: 10%, and Others: 76%
- By Region: North America: 40%, Europe: 32%, APAC: 20%, and RoW: 8%
Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
This report studies the bowel management systems market based on product, patient type, end user, and region. The report also studies factors affecting market growth, it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of market segments with respect to the four key regions and respective countries.
Reasons To Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis? market ranking and share analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the bowel management systems market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares.